213 related articles for article (PubMed ID: 16448844)
1. Recombinant alphaviruses as vectors for anti-tumour and anti-microbial immunotherapy.
Riezebos-Brilman A; de Mare A; Bungener L; Huckriede A; Wilschut J; Daemen T
J Clin Virol; 2006 Mar; 35(3):233-43. PubMed ID: 16448844
[TBL] [Abstract][Full Text] [Related]
2. Alphavirus DNA and particle replicons for vaccines and gene therapy.
Polo JM; Gardner JP; Ji Y; Belli BA; Driver DA; Sherrill S; Perri S; Liu MA; Dubensky TW
Dev Biol (Basel); 2000; 104():181-5. PubMed ID: 11713818
[TBL] [Abstract][Full Text] [Related]
3. Alphavirus vectors for cancer gene therapy (review).
Yamanaka R
Int J Oncol; 2004 Apr; 24(4):919-23. PubMed ID: 15010830
[TBL] [Abstract][Full Text] [Related]
4. Non-viral amplification systems for gene transfer: vectors based on alphaviruses.
Smerdou C; Liljeström P
Curr Opin Mol Ther; 1999 Apr; 1(2):244-51. PubMed ID: 11715947
[TBL] [Abstract][Full Text] [Related]
5. Alphavirus vectors for cancer therapy.
Quetglas JI; Ruiz-Guillen M; Aranda A; Casales E; Bezunartea J; Smerdou C
Virus Res; 2010 Nov; 153(2):179-96. PubMed ID: 20692305
[TBL] [Abstract][Full Text] [Related]
6. Alphavirus-based vaccines.
Lundstrom K
Curr Opin Mol Ther; 2002 Feb; 4(1):28-34. PubMed ID: 11883692
[TBL] [Abstract][Full Text] [Related]
7. Biology and application of alphaviruses in gene therapy.
Lundstrom K
Gene Ther; 2005 Oct; 12 Suppl 1():S92-7. PubMed ID: 16231060
[TBL] [Abstract][Full Text] [Related]
8. Recombinant cancer vaccines based on viral vectors.
Moingeon P
Dev Biol (Basel); 2004; 116():117-22; discussion 133-43. PubMed ID: 15603188
[TBL] [Abstract][Full Text] [Related]
9. A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.
Riezebos-Brilman A; Walczak M; Regts J; Rots MG; Kamps G; Dontje B; Haisma HY; Wilschut J; Daemen T
Gene Ther; 2007 Dec; 14(24):1695-704. PubMed ID: 17928874
[TBL] [Abstract][Full Text] [Related]
10. Role of regulatory T-cells in immunization strategies involving a recombinant alphavirus vector system.
Walczak M; Regts J; van Oosterhout AJ; Boon L; Wilschut J; Nijman HW; Daemen T
Antivir Ther; 2011; 16(2):207-18. PubMed ID: 21447870
[TBL] [Abstract][Full Text] [Related]
11. Application of Alphaviral Vectors for Immunomodulation in Cancer Therapy.
Zajakina A; Spunde K; Lundstrom K
Curr Pharm Des; 2017; 23(32):4906-4932. PubMed ID: 28641531
[TBL] [Abstract][Full Text] [Related]
12. Alphavirus vectors and vaccination.
Rayner JO; Dryga SA; Kamrud KI
Rev Med Virol; 2002; 12(5):279-96. PubMed ID: 12211042
[TBL] [Abstract][Full Text] [Related]
13. Induction of multiepitopic and long-lasting immune responses against tumour antigens by immunization with peptides, DNA and recombinant adenoviruses expressing minigenes.
Durántez M; López-Vázquez AB; de Cerio AL; Huarte E; Casares N; Prieto J; Borrás-Cuesta F; Lasarte JJ; Sarobe P
Scand J Immunol; 2009 Feb; 69(2):80-9. PubMed ID: 19144076
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of alphavirus vector-induced human papilloma virus-specific immune and anti-tumour responses by co-expression of interleukin-12.
Riezebos-Brilman A; Regts J; Chen M; Wilschut J; Daemen T
Vaccine; 2009 Jan; 27(5):701-7. PubMed ID: 19041356
[TBL] [Abstract][Full Text] [Related]
15. Alphavirus-based vaccines.
Lundstrom K
Viruses; 2014 Jun; 6(6):2392-415. PubMed ID: 24937089
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic and prophylactic applications of alphavirus vectors.
Atkins GJ; Fleeton MN; Sheahan BJ
Expert Rev Mol Med; 2008 Nov; 10():e33. PubMed ID: 19000329
[TBL] [Abstract][Full Text] [Related]
17. An alphavirus-based therapeutic cancer vaccine: from design to clinical trial.
Singh A; Koutsoumpli G; van de Wall S; Daemen T
Cancer Immunol Immunother; 2019 May; 68(5):849-859. PubMed ID: 30465060
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of angiogenesis by a Semliki Forest virus vector expressing VEGFR-2 reduces tumour growth and metastasis in mice.
Lyons JA; Sheahan BJ; Galbraith SE; Mehra R; Atkins GJ; Fleeton MN
Gene Ther; 2007 Mar; 14(6):503-13. PubMed ID: 17167497
[TBL] [Abstract][Full Text] [Related]
19. Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics.
Breckpot K; Aerts JL; Thielemans K
Gene Ther; 2007 Jun; 14(11):847-62. PubMed ID: 17361214
[TBL] [Abstract][Full Text] [Related]
20. Semliki Forest virus-based immunotherapy for cancer.
Lundstrom K
Expert Opin Biol Ther; 2020 Jun; 20(6):593-599. PubMed ID: 32050824
[No Abstract] [Full Text] [Related]
[Next] [New Search]
